Abstract
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) play important roles in the remodeling of connective tissues associated with normal mammalian development and growth, and in the degradative processes accompanying diseases such as rheumatoid arthritis, pulmonary emphysema or tumor cell invasion and metastasis (1). Because of the importance of these proteins in both normal and pathological conditions, over the last years many groups have tried to clone the diverse MMPs mediating these matrix remodeling events as well as the different TIMPs able to balance their proteolytic activities. The first evidence for the occurrence of MMPs was reported about 35 yr ago by Gross and Lapiere who described the presence of diffusible collagenolytic factors in tissue cultures of bullfrog tadpoles (2). Some years after this finding, several groups independently reported the existence of naturally occurring metalloproteinase inhibitors known as TIMPs and active against most members of the MMP family (3). The utilization of standard biochemical methods allowed the isolation of the first MMP and TIMP family members and their subsequent physico-chemical characterization. However, these studies were seriously hampered by the small amount of proteases and inhibitors usually found in normal conditions. The observation that these proteins were much more abundant in a series of pathological conditions such as inflammatory or tumor processes or during extracellular matrix remodeling events, facilitated the identification of additional members of both families and the molecular cloning of the first MMPs and TIMPs. More recently, the advent of more powerful molecular biology techniques and improved cloning strategies has made it possible to identify a large number of novel MMP and TIMP family members. To date, 18 distinct MMPs have been identified, cloned, and characterized in vertebrates (4). In addition, MMPs have been also cloned from embryonic sea urchin (5), green alga (6) and soybean leaves (7). The complexity of the TIMP family has also expanded during the last years and a total of 4 distinct inhibitors with ability to control the proteolytic activity of MMPs have been cloned and characterized at the molecular level (8). These new additions to the growing list of MMPs and TIMPs have provided much more complexity to the field but have also opened new views on the role of these proteins in normal and pathological processes. Thus, evidence is accumulating that MMPs are not exclusively involved in the proteolytic degradation of extracellular matrix components, playing also direct roles in essential cellular processes such as differentiation, proliferation, angiogenesis and apoptosis (9). Similarly, TIMPs appear to have additional roles other than their direct inhibition of MMP proteolytic activity, and a number of reports have described their involvement in cell growth (10). The delineation of expanding roles for these proteins in a wide variety of biological processes has also reinforced previous observations indicating that misregulation of these proteases and inhibitors can have important pathological consequences. Nevertheless, it seems clear that most of this progress has been only possible by the cloning of an unexpected large number of these proteins. This chapter will give an overview of the different strategies used for cloning MMPs and TIMPs and their application to the identification and characterization of putative yet unknown members of these protein families that play essential roles in both normal and pathological conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Birkedal-Hansel H., Moore W. G. I., Bodden M. K., Windsor L. J., Birkedal-Hansen B., DeCarlo A., and Engler J. A. (1993) Matrix metalloproteinases a review. Crit. Rev. Oral Biol. Med. 4, 197–250.
Gross J. and Lapiere C. M. (1962) Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc. Natl. Acad. Sci. USA 48, 1014–1022.
Gomez D. E., Alonso D. F., Yoshiji H., and Thorgeirsson U. P. (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74, 11–122
Uría J. A., Jiménez M. J., Balbín M., Freije J. P. and López-Otín C. (1998) Differential effects of TGFb on the expression of collagenase-1 and collagenase-3 in human fibroblasts. J. Biol. Chem. 273, 9769–9777
Lepage T. and Gache C. (1990) Early expression of a collagenase-like hatching enzyme gene in the sea urchin embryo. EMBO J. (bd9), 3003–3012.
Kinoshita T., Fuzukawa H., Shimada T., Saito T., and Matsuda Y. (1992) Primary structure and expression of a gamete lytic enzyme in Chlamydomonas reinhardtii: similarity of functional domains to matrix metalloproteases. Proc. Natl. Acad. Sci. USA 89, 4693–4697.
Pak J. H., Liu C. Y., Huangpu J. and Graham J. S. (1997) Construction and characterization of the soybean leaf metalloproteinase cDNA. FEBS Lett. 404, 283–288.
Greene J., Wang M., Liu Y. E., Raymond L. A., Rosen C., and Shi Y. E. (1996) Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J. Biol. Chem. 271, 30,375–30,380.
Werb Z. (1997) ECM and cell surface proteolysis: Regulating cellular ecology. Cell 91, 439–442.
Hayakawa T., Yamashita K., Tanzawa K., Uchijima E. and Iwata K. (1992) Growth promoting activity of tissue inhibitor of metalloproteinase-1 (TIMP-1) for a wide range of cells. FEBS Lett. 298, 29–32.
Matrisian L. M., LeRoy P., Ruhlmann C., Gesnel C., and Breathnach. (1986) Isolation of the oncogene and epidermal growth factor-induced transin gene:complex control in rat fibroblasts. Mol. Cell. Biol. 6, 1679–1686.
Basset P., Bellocq J. P., Wolf C., Stoll I., Huntin P., Limacher J. M., Podhajcer O. L., Chenard M. P., Rio M. C., and Chambon P. (1990) A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature, 348, 699–704.
Goldberg G. I., Wilhelm S. M., Kronberger A., Bauer E. A., Grant G. A., and Eisen A. Z. (1986) Human fibroblast collagenase: Complete primary structure and homology to an oncogene transformation-induced rat protein. J. Biol. Chem. 261, 6600–6605.
Whitham S. E., Murphy G., Angel P., Rahmsdorf H-J., Smith B. J., Lyons A., Harris T. J. R., Reynolds J. J., Herrlich P., and Docherty A. J. P. (1986) Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem. J. 240, 913–916.
Templeton N. S., Brown P. D., Levy A. T., Margulies I. M. K., Liotta L. A., and Stetler-Stevenson W. G. (1990) Cloning and characterization of human tumor cell interstitial collagenase. Cancer Res. 50, 5431–5437.
Shingleton W. D., Hodges D. J., Brick P., and Cawston T. E. (1997) Collagenase: a key enzyme in collagen turnover. Biochem. Cell. Biol. 74, 759–775.
Devarajan P., Mookhtiar K., Wart H. V., and Berliner N. (1991). Structure and expression of the cDNA encoding human neutrophil collagenase. Blood 77, 2731–2738.
Dubnick M., Lewis L. K., and Mount D. W. (1988) BIGPROBE: A complete program that predicts the sequence of long oligonucleotide probes with high reliability. Nucleic. Acid. Res. 16, 1703.
Hasty K. A., Pourmotabbed T. F., Goldberg G. I., Thompson J. P., Spinella D. G., Stevens R. M., and Mainardi C. L. (1990) Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. J. Biol.Chem. 265, 11,421–11,424.
Wilhelm S. M., Collier I. E., Kronberger A., Eisen A. Z., Marmer B. L., Grant G. A., Bauer E. A., and Goldberg G. I. (1987) Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc. Natl. Acad. Sci. USA 84, 6725–6729.
Collier I. E., Wilhelm S. M., Eisen A. Z., Marmer B. L., Grant G. A., Seltzer J. L., Kronberger A., He C., Bauer E. A., and Goldberg G. I. (1988) H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J. Biol.Chem., 263, 6579–6587.
Wilhelm S. M., Collier I. E., Marmer B. L., Eisen A. Z., Grant G. A., and Goldberg G. I. (1989) SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase wich is identical to that secreted by normal human macrophages. J. Biol. Chem. 264, 17,213–17,221.
Stricklin G. P. and Welgus H. G. (1983) Human skin fibroblast collagenase inhibitor. Purification and biochemical characterization. J. Biol. Chem. 258, 12,252–12,258.
Docherty A. J. P., Lyons A., Smith B. J., Wright E. M., Stephens P. E., and Harris T. J. R. (1985) Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 318, 66–69.
Gasson J. C., Golde D. W., Kaufman S. E., Westbrook C. A., Hewick R. M., Kaufman R. J., Wong G. G., Temple P. A., Leary A., Brown E. L., Orr E. C., and Clark S. C. (1985) Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature 315, 768–771.
Goldberg G. I., Marmer B. L., Grant G. A., Eisen A. Z., Wilhelm S., and He C. (1989) Human 72-kDa type IV collagenase forms with a tissue inhibitor of metalloproteases designated TIMP-2. Proc. Natl. Acad. Sci. USA 86, 8207–8211.
Stetler-Stevenson W. G., Krutzsch H. C., and Liotta L. A. (1989) Tissue inhibi tor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J. Biol. Chem. 264, 17,374–17,378.
Boone T. C., Johnson M. J., De Clerck Y. A., and Langley K. E. (1990) cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases. Proc. Natl. Acad. Sci. U.S.A. 87, 2800–2804.
Breathnach R. Matrisian L. M., Gesnel M. C. Staub A., and Leroy P. (1987) Sequences coding for part of oncogene-induced transin are higly conserved in a related rat gene. Nucleic Acid Res. 15, 1139–1151.
Muller D., Quantin B., Gesnel M-C., Millon-Collard R., Abecassis J., and Breathnach R. (1988) The collagenase gene family in human consists of at least four members. Biochem. J. 253, 187–192.
Abramson S. R., Conner G. E., Nagase H., Neuhaus Y., and Woessner J. F.(1995) Characterization of rat uterine matrilysin and its cDNA: relationship to human pump-1 and activation of procollagenases. J. Biol. Chem. 270, 16,016–16,022.
Stolow M. A., Bauzon D. D., Li J., Sedgwick T., Liang V.C-T., Sang Q. A., and Shi Y-B. (1996) Identification and characterization of a novel collagenase in Xenopus laevis: possible roles during frog development. Mol. Biol. Cell 7, 1471–1483.
Shapiro S. D., Kobayashi D. K., and Ley T. J. (1993) Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem. 268, 23,824–23,829.
Llano E., Pendás A. M., Knaüper V., Sorsa T., Salido E., Murphy G., Simmer J. P., Bartlett J. D., and López-Otín C. (1997) Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry 36, 15,101–15,108.
Freije J. M. P., Díez-Itza I., Balbín M., Sánchez L. M., Blasco R., Tolivia J., and López-Otín C. (1994) Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J. Biol.Chem. 269, 16,766–16,773.
Mitchell P. G., Magna H. A., Reeves L. M., Lopresti-Morrow L. L., Yocum S. A., Rosner P. J., Geoghegan K. F., and Hambor J.E. (1996) Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Invest. 97, 761–768.
Stahle-Bäckdahl M., Sandsted B., Bruce K., Lindahl A., Jiménez M. G., Vega J. A., and López-Otín C. (1997) Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab. Invest. 76, 717–728.
Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., and Seiki M. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370, 61–65.
Will H. and Hinzmann B. (1995) cDNA sequence and mRNA distribution of a novel human matrix metalloproteinase with a potential transmembrane domain. Eur. J. Biochem. 231, 602–608.
Takino T., Sato H., Shinagawa A., and Seiki M. (1995) Identification of the second membrane-type matrix metalloproteinase (MT-MMP2) gene from a human placenta cDNA library. J. Biol. Chem., 270, 23,013–23,020.
Puente X. S., Pendás A. M., Llano E., Velasco G. and López-Otín C. (1996) Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res. 56, 944–949.
Shapiro S. D., Griffin G. L., Gilbert D., Jenkins N. A., Copeland N. G., Welgus H. G., Senior R. M., and Ley T. J. (1992) Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase. J. Biol.Chem. 267, 4664–4671.
Bartlett J. D., Simmer J. P., Xue J., Margolis H. C., and Moreno E. C. (1996) Molecular cloning and mRNA tissue distribution of a novel matrix metalloproteinase isolated from a porcine enamel organ. Gene 183, 123–128.
Yang M., Murray M. T., and Kurkinen M. (1997) A novel matrix metalloproteinase gene (XMMP) encoding vitronectin-like motifs is transiently expressed in Xenopus laevis early embryo development. J. Biol. Chem. 272, 13,527–13,533.
Uría J. A., Ferrando A. A., Velasco G., Freije J. M. P., and López-Otín C.(1994) Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family. Cancer Res. 54, 2091–2094.
Silbiger S. M., Jacobsen V. L., Cupples R. L., and Koski R. A. (1994) Cloning of cDNAs encoding human TIMP-3, a novel member of the tissue inhibitor of metalloproteinase family. Gene 141, 293–297.
Apte S. S., Mattei M. G., and Olsen B. R. (1994) Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22. Genomics 19, 86–90.
Pavloff N., Staskus P. W., Kishnani N. S., and Hawkes S. P. (1992) A new inhibitor of metalloproteinases from chicken: ChIMP-3. J. Biol. Chem. 267, 17,321–17,326.
Anand-Apte B., Bao L., Smith R., Iwata K., Olsen B. R., Zetter B. and Apte S. S. (1997) A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth. Biochem. Cell Biol. 74, 853–862.
Weber B. H., Vogt G., Pruett R. C., Stohr H., and Felbor U. (1994) Mutations in the tissue inhibitor of metalloproteinase-3 (TIMP-3) in patients with Sorsby’s fundus distrophy. Nat. Genet. 8, 352–356.
Adams M. D., Kelley J. M., Gocayne J. D., Dubnick M., et al., (1991) Initial assessment of human gene diversity and expression pattern based upon 83 million nucleotides of cDNA sequence. Nature 377, 3–17.
Soares M. B., Bonaldo M. F., Jelene P., Su L., Lawton L., and Efstratiadis A. (1994) Construction and characterization of a normalized cDNA library. Proc.Natl. Acad. Sci. USA 91, 9228–9232.
Wolfsberg T. G. and Landsman D. (1997) A comparison of expressed sequence tags (ESTs) to human genomic sequences. Nucleic Acids Res. 25, 1626–1632.
Pendás A. M., Knäuper V., Puente X. S., Llano E., Mattei M. G., Apte S., Murphy G. and López-Otín C. (1997) Identification and characterization of a novel matrix metalloproteinase with unique structural characteristics, chromosomal location and tissue distribution. J. Biol. Chem. 272: 4281–4286.
Liu Y. E., Wang M., Greene J., Su J., Ullrich S., Li H., Sheng S., Alexander P., Sang Q. A., and Shi Y. E. (1997) Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP-4). J. Biol. Chem. 272, 20,479–20,483.
Guruajan R. Grenet J., Lahti J. M., and Kidd V. J. (1998) Isolation and characterization of two novel metalloproteinase genes linked to Cdc2L locus on human chromosome 1p36.3. Genomics 52, 101–106.
Velasco G., Pendas A. M., Fueyo A., Knauper V., Murphy G., and López-Otin C. (1999) Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members. J. Biol. Chem. 274, 4570–4576.
Llano F., Pendás A. M., Freije J. P., Nakano A., Knauper V., Murphy G., and López-Otin C. (1999) Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase A overexpressed in brain tumors. Cancer Res. 59, 2570–2576.
Velasco G., Cal S., Merlos-Suarez A., Ferrando A. A., Alvarez S., Nakano A., Arribas J., and López-Otin C. (2000) Humana MT6-MMP identification progelatinase A activation, and expression in brain tumors. Cancer Res. 60, 877–882.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc.
About this protocol
Cite this protocol
Velasco, G., López-Otín, C. (2001). Strategies for Cloning New MMPs and TIMPs. In: Clark, I.M. (eds) Matrix Metalloproteinase Protocols. Methods in Molecular Biology™, vol 151. Humana Press. https://doi.org/10.1385/1-59259-046-2:025
Download citation
DOI: https://doi.org/10.1385/1-59259-046-2:025
Publisher Name: Humana Press
Print ISBN: 978-0-89603-733-5
Online ISBN: 978-1-59259-046-9
eBook Packages: Springer Protocols